USPTO Director: Board Abused Discretion by Instituting Two IPRs on Same Patent Based on Competing Claim Constructions

August 5, 2025

Reading Time : 2 min

In a recent decision designated as Informative, the USPTO Director determined that the Patent Trial and Appeal Board abused its discretion by instituting two inter partes review proceedings challenging the same patent, based on petitions advancing different constructions of the same claim term. The Director expressed concerns that permitting multiple petitions based on alternative claim constructions effectively circumvents word count limitations, strains board resources, and undermines procedural efficiency.

The two petitions primarily presented two different constructions of a certain claim term—one broader and one narrower. Each petition advanced obviousness grounds according to the respective construction. In total, the two petitions presented eight grounds of unpatentability with significant overlap between them. Patent owner did not take a position on the proper construction of the term in its preliminary response, arguing instead that the claims were not unpatentable under either interpretation. The board instituted review based on both petitions because of the large number of claims and the complex subject matter, which was further complicated by the fact that the patent owner might argue for a narrow construction of the claim term petitioner identified.

The patent owner sought Director Review, arguing that the board abused its discretion in instituting both proceedings against the same claims of the same patent where no exceptional circumstances justified a second proceeding. The petitioner argued that institution was proper because each petition was based on a distinct interpretation of the claim term, and the patent owner had not taken a position on its meaning.

The Director determined that the board abused its discretion in granting institution of both petitions. Citing the board’s Consolidated Trial Practice Guide, the Director emphasized that “one petition should be sufficient to challenge the claims of a patent in most situations” and multiple petitions are not necessary in the vast majority of cases. The director found that allowing two petitions challenging the same claims under alternate claim constructions effectively expands the word count limits, increases the burden on the board, and raises concerns about fairness, timing, and efficiency.

Importantly, the director rejected the board’s rationale that the patent owner not advancing a claim construction position was a reason to institute both petitions. Rather, the Director stated that the board should have construed the claim term and instituted review of only one, if any, of the petitions. The Director remanded and authorized the patent owner to submit a brief addressing how the board should construe the claim term, to which the petitioner was authorized a reply. In its brief on remand, patent owner argued, among other things, that both petitions violated the requirement that a petitioner explain how the claim is to be construed under 37 C.F.R. § 42.104(b)(3). According to patent owner, the petitioner here attempted to shift that burden to the board and the patent owner.

Practice Tip:

Advancing alternate claim constructions in separate petitions, without more, is unlikely to justify multiple IPRs targeting the same patent. Petitioners should provide their proposed construction in their petition and, if necessary, can address an alternative construction that patent owner might seek. Conversely, patent owners should consider whether taking a position on claim construction could bolster non-institution arguments.

CrowdStrike, Inc. v. GoSecure, Inc., Nos. IPR2025-00068 & IPR2025-00070, Paper 25 (P.T.A.B. June 25, 2025)

Share This Insight

Previous Entries

IP Newsflash

August 5, 2025

The Federal Circuit recently vacated a decision by the Patent Trial and Appeal Board after concluding that the board’s analysis of licensing evidence offered as a secondary consideration of nonobviousness constituted legal error and was not supported by substantial evidence. According to the court, the board applied a more exacting and improperly heightened nexus standard than is required by law for license evidence.

...

Read More

IP Newsflash

August 5, 2025

In a recent decision designated as Informative, the USPTO Director determined that the Patent Trial and Appeal Board abused its discretion by instituting two inter partes review proceedings challenging the same patent, based on petitions advancing different constructions of the same claim term. The Director expressed concerns that permitting multiple petitions based on alternative claim constructions effectively circumvents word count limitations, strains board resources, and undermines procedural efficiency.

...

Read More

IP Newsflash

July 25, 2025

Earlier this year, the Federal Circuit’s decision in Qualcomm Inc. v. Apple Inc. (Qualcomm II) raised questions about the extent to which petitioners can rely on applicant admitted prior art (“AAPA”) in inter partes review proceedings.  The Federal Circuit’s recent decision in Shockwave Medical, Inc. v. Cardiovascular Sys., Inc. largely cabins the Qualcomm II decision to its particular facts and makes clear that AAPA can be used as evidence of background knowledge as part of an obviousness argument.

...

Read More

IP Newsflash

July 11, 2025

The Federal Circuit recently reversed a PTAB determination on remand that a patent was obvious over applicant admitted prior art (“AAPA”) in combination with prior art patents, holding that expressly designating AAPA as a “basis” for a ground is improper under 35 U.S.C. § 311(b). In doing so, the Court rejected the PTAB’s “blanket rule” that “AAPA used in combination with prior art patents or printed publications under § 311(b) is ipso facto not the basis or part of the basis of a ground.” Ultimately, while the case clarifies that expressly listing AAPA in an IPR ground is improper, the precise line between proper and improper uses of AAPA in other instances remains unclear.

...

Read More

IP Newsflash

July 1, 2025

In an appeal from an inter partes review, the Federal Circuit recently clarified that the enablement inquiry applied to prior art references in the context of an anticipation defense differs from the enablement inquiry applied when evaluating the claims of a patent.

...

Read More

IP Newsflash

June 26, 2025

The Northern District of Ohio denied a motion to compel the plaintiff to produce test results referenced in its initial disclosures and complaint. The court found that because the “test results are not facts but rather are opinions,” the information was protected as work product. Furthermore, because that testing would not be used as evidence in the litigation, the defendant was not prejudiced.

...

Read More

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.